Skip to main content

Treatment Clinical Trials for Prostate Cancer

Review the prostate cancer treatment clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 276-300 of 319

4AP for the Treatment of Nerve Injury from Retropubic Prostatectomy in Patients with Localized Prostate Cancer
Status: Active
Location: Banner University Medical Center - Tucson, Tucson, Arizona
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men with Localized Prostate Cancer on Active Surveillance
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York
Discontinuation of Standard LHRH Agonist Therapy in Elderly Prostate Cancer Patients
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Focal Therapy (Transvesical Single-Port Robotic Partial Prostatectomy versus High-Intensity Focused Ultrasound) for the Treatment of Patients with Prostate Cancer
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Image Guided Tumor Focused Radiation Therapy compared to Standard Whole Prostate Radiation Therapy for the Treatment of Patients with Intermediate and High-risk Prostate Cancer, RADTARGET Trial
Status: Active
Location: UC San Diego Moores Cancer Center, La Jolla, California
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Cone-Beam Computed Tomography-Based Adaptive Stereotactic Body Radiation Therapy for the Treatment of Intermediate- and Favorable High-Risk Prostate Cancer, DE-CART Trial
Status: Active
Location: Fox Chase Cancer Center, Philadelphia, Pennsylvania
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Image-Guidance and Online Adaptation with Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Computed Tomography-Guided Stereotactic Body Radiation Therapy with Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Two-Fraction High Dose Rate Brachytherapy Delivered Three Hours Apart for Localized Prostate Cancer
Status: Active
Location: University of California San Francisco, San Francisco, California
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
Status: Active
Location: See ClinicalTrials.gov
ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer
Status: Active
Location: See ClinicalTrials.gov
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Status: Active
Location: See ClinicalTrials.gov
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Evaluation of AP-002 in Patients With Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Status: Active
Location: University of California San Francisco, San Francisco, California
Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
Status: Active
Location: UF Health Cancer Institute - Gainesville, Gainesville, Florida
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Status: Active
Location: 2 locations
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
Status: Active
Location: See ClinicalTrials.gov
A Study Evaluating MM-310 in Patients With Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
PM14 Administered Intravenously to Patients with Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov